{"product_id":"genetics-neurology-behavior-and-diet-in-parkinsons-disease-the-neuroscience-of-parkinson-s-disease-volume-2-hardback-9780128159507","title":"Genetics, Neurology, Behavior, and Diet in Parkinson's Disease; The Neuroscience of Parkinson’s Disease, Volume 2 (Hardback) 9780128159507","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eGenetics, Neurology, Behavior, and Diet in Parkinson's Disease\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eThe Neuroscience of Parkinson’s Disease, Volume 2\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003eProvides a single reference covering different scientific domains of the neuropathology underlying Parkinson's disease—from pathology to therapy\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eColin R Martin (Edited by), Victor R Preedy (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780128159507, Elsevier Science\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 30 October 2020\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e762 pages\u003cbr\u003e23.4 x 19 x 3.9 cm, 1.93 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003ci\u003eGenetics, Neurology, Behavior, and Diet in Parkinson's Disease: The Neuroscience of Parkinson’s Disease, Volume 2\u003c\/i\u003e provides a single source of material covering different scientific domains of neuropathology underlying this condition. The book covers a wide range of subjects and unravels the complex relationships between genetics, molecular biology, pharmaceutical chemistry, neurobiology, imaging, assessments, and treatment regimens. It fills a much-needed gap as a \"one-stop\" synopsis of everything to do with the neurology and neuroscience related to Parkinson’s disease—from chemicals and cells to individuals. It is an invaluable resource for neuroscientists, neurologists, and anyone in the field.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003ePart I: Genetics, molecular and cellular biology\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e2. Alpha-synuclein gene and Parkinson’s disease Athina-Maria Simitsi, Chistos Koros \u003ci\u003eand\u003c\/i\u003e Leonidas Stefanis\u003c\/p\u003e \u003cp\u003e3. The DJ-1 gene and protein: links with Parkinson’s disease Vanessa J. Musco, Sarah J. Annesley \u003ci\u003eand\u003c\/i\u003e Paul R. Fisher\u003c\/p\u003e \u003cp\u003e4. Regulation of tyrosine hydroxylase: relevance to Parkinson’s disease Gelareh Alam \u003ci\u003eand\u003c\/i\u003e Jason R. Richardson\u003c\/p\u003e \u003cp\u003e5. Linking glucocerebrosidase gene (GBA) variants and Parkinson’s disease ctoria Berge-Seidl \u003ci\u003eand\u003c\/i\u003e Mathias Toft\u003c\/p\u003e \u003cp\u003e6. Astrocytes and microglia in Parkinson’s disease and animal models Katarzyna Kuter\u003c\/p\u003e \u003cp\u003e7. The role of autophagy in Parkinson’s disease etiopathogenesis Emanuel Candeias, Jãao Duarte Magalhães, Daniel Santos, Helena Costa, Diana F. Silva, Ana Raquel Esteves \u003ci\u003eand\u003c\/i\u003e Sandra Morais Cardoso\u003c\/p\u003e \u003cp\u003e8. The mitochondrial network in Parkinson’s disease Andreas Aufschnaiter, Verena Kohler \u003ci\u003eand\u003c\/i\u003e Sabrina Büttner\u003c\/p\u003e \u003cp\u003e9. Signal transduction in Parkinson’s disease: modulation of neurotransmission, symptomatology, and therapy Mattia Volta\u003c\/p\u003e \u003cp\u003e10. Oxidative stress signaling and regulated cell death in Parkinson’s disease Carlos Velez-Pardo \u003ci\u003eand\u003c\/i\u003e Marlene Jimenez-Del-Rio\u003c\/p\u003e \u003cp\u003e11. Subcellular-specific alpha-synuclein in Parkinson’s disease Benjamin Rosen, Ketan S. Patil, Guido W. Alves \u003ci\u003eand\u003c\/i\u003e Simon G. Møller\u003c\/p\u003e \u003cp\u003e12. Melanocortin 1 receptor: Parkinson’s disease, melanoma risk, and neuroprotection Gemma Tell-Marti, Joan Anton Puig-Butillé \u003ci\u003eand\u003c\/i\u003e Susana Puig\u003c\/p\u003e \u003cp\u003e13. Energy regulation and Parkinson’s disease Liting Hang \u003ci\u003eand\u003c\/i\u003e Kah-Leong Lim\u003c\/p\u003e \u003cp\u003e14. Linking rotigotine, Parkinson’s disease, and brain-derived neurotrophic factor Kazuhiro Sohya, Kazunori O’Hashi \u003ci\u003eand\u003c\/i\u003e Hiroshi Kunugi\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart II: Neurology, physiology and imaging\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e15. The different syndromes in Parkinson’s disease: an overview Nikolaos Giagkou \u003ci\u003eand\u003c\/i\u003e Maria Stamelou\u003c\/p\u003e \u003cp\u003e16. Neuromolecular imaging in Parkinson’s disease Patricia A. Broderick \u003ci\u003eand\u003c\/i\u003e Leslie Wenning\u003c\/p\u003e \u003cp\u003e17. Interlinking brain mapping and Parkinson’s disease: MRI analysis, nigrosome 1 and nigrosome 4 Eung Yeop Kim, Young Hee Sung \u003ci\u003eand\u003c\/i\u003e Jongho Lee\u003c\/p\u003e \u003cp\u003e18. Interconnecting Parkinson’s disease: the use of computed tomography and microelectrode recording in DBS surgery Ryan B. Kochanski \u003ci\u003eand\u003c\/i\u003e Sepehr Sani\u003c\/p\u003e \u003cp\u003e19. Linking diffusion tensor imaging, microstructures and Parkinson’s disease Yu Zhang, Norbert Schuff, I-Wei Wu \u003ci\u003eand\u003c\/i\u003e Duygu Tosun\u003c\/p\u003e \u003cp\u003e20. Detecting parkinsonian degeneration in lateroventral tier of substantia nigra pars compacta with MRI Jason Langley, Daniel E. Huddleston \u003ci\u003eand\u003c\/i\u003e Xiaoping P. Hu\u003c\/p\u003e \u003cp\u003e21. Vagal motoneurons in Parkinson’s disease Ruth E. Musgrove, Wei-Hua Chiu \u003ci\u003eand\u003c\/i\u003e Joshua A. Goldberg\u003c\/p\u003e \u003cp\u003e22. Circadian clock disruption and neuroinflammation in Parkinson’s disease: a new perspective  Elisabetta Lauretti \u003ci\u003eand\u003c\/i\u003e Domenico Praticò\u003c\/p\u003e \u003cp\u003e23. Motor cortex stimulation in Parkinson’s disease Angelo Lavano, Giusy Guzzi, Attilio Della Torre \u003ci\u003eand\u003c\/i\u003e Domenico La Torre\u003c\/p\u003e \u003cp\u003e24. Action programming disorders associated with Parkinson’s disease Kenneth M. Heilman\u003c\/p\u003e \u003cp\u003e25. The striatal medium spiny neurons: what they are and how they link with Parkinson’s disease Fu-Ming Zhou\u003c\/p\u003e \u003cp\u003e26. Disruptions of frontostriatal language functions in Parkinson’s disease Adolfo M. García, Yamile Bocanegra, Agustina Birba, Juan Rafael Orozco-Arroyave, Lucas Sedeño \u003ci\u003eand\u003c\/i\u003e Agustín Ibañez\u003c\/p\u003e \u003cp\u003e27. Alpha-synuclein and neuroinflammation in Parkinson’s disease Tatiana Varanita \u003ci\u003eand\u003c\/i\u003e Luigi Bubacco\u003c\/p\u003e \u003cp\u003e28. Tau and its interactions with other proteins in neurodegenerative diseases Katelyn H. Mroczek, Sarah J. Annesley \u003ci\u003eand\u003c\/i\u003e Paul R. Fisher\u003c\/p\u003e \u003cp\u003e29. Interaction between brain angiotensin and dopaminergic systems and Parkinson’s disease Jose Luis Labandeira-Garcia, Pablo Garrido-Gil, Maria A. Pedrosa, Carmen M. Labandeira \u003ci\u003eand\u003c\/i\u003e Ana I. Rodriguez-Perez\u003c\/p\u003e \u003cp\u003e30. Restoring dopamine levels in Parkinson’s disease: neuronal pathways, agonists and antiinflammatory agents Ágatha Oliveira-Giacomelli, C.M. Albino, Hellio Danny Nóbrega de Souza \u003ci\u003eand\u003c\/i\u003e Henning Ulrich\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart III: Behaviour and psychopathology\u003c\/b\u003e \u003c\/p\u003e \u003cp\u003e31. Motivation and motivational aspects of Parkinson’s disease Abdeslam Chagraoui, Emilie Puginier \u003ci\u003eand\u003c\/i\u003e Philippe De Deurwaerdère\u003c\/p\u003e \u003cp\u003e32. Linking anxiety, cognitive and sensory deficits to gait and balance deficits in Parkinson’s disease Quincy J. Almeida\u003c\/p\u003e \u003cp\u003e33. Motor programs interlinking gait and bradykinesia in Parkinson’s disease Tateo Warabi, Kiyoharu Inoue \u003ci\u003eand\u003c\/i\u003e Nobuo Yanagisawa\u003c\/p\u003e \u003cp\u003e34. Olfactory disturbances in Parkinson’s disease Lais S. Rodrigues, Juliane Fagotti, Adriano D.S. Targa, Ana Carolina D. Noseda, Jessica L. Ilkiw, Flavia W.C. Dorieux \u003ci\u003eand\u003c\/i\u003e Marcelo M.S. Lima\u003c\/p\u003e \u003cp\u003e35. Interlinking dementia in Parkinson’s disease: nutritional correlates of body composition Arthur Oscar Schelp, Jéssica Emy Komuro, José Eduardo Corrente \u003ci\u003eand\u003c\/i\u003e Silvia Justina Papini\u003c\/p\u003e \u003cp\u003e36. The role of the gastrointestinal system and gut microbiota in Parkinson’s disease Jade Kenna \u003ci\u003eand\u003c\/i\u003e Ryan S. Anderton\u003c\/p\u003e \u003cp\u003e37. Swallowing impairment in Parkinson’s disease Maira Rozenfeld Olchik, Marina Padovani \u003ci\u003eand\u003c\/i\u003e Annelise Ayres\u003c\/p\u003e \u003cp\u003e38. The Mini Nutritional Assessment (MNA) and applications to Parkinson’s disease Svetlana Tomic\u003c\/p\u003e \u003cp\u003e39. The efficacy of Bacopa monnieri extract in modulating Parkinson’s disease Dr. Ravikumar Hosamani\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart V: Models, modelling and resources\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e40. 6-hydroxydopamine-induced model of Parkinson’s disease Katarzyna Kaczynska \u003ci\u003eand\u003c\/i\u003e Kryspin Andrzejewski\u003c\/p\u003e \u003cp\u003e41. Knockdown transgenic Drosophila and Parkinson’s disease Marlene Jimenez-Del-Rio \u003ci\u003eand\u003c\/i\u003e Carlos Velez-Pardo\u003c\/p\u003e \u003cp\u003e42. Neuroprotection in animal models of Parkinson’s disease: exploring exercise, sound, and light John Mitrofanis\u003c\/p\u003e \u003cp\u003e43. Modeling with the A53T a-synuclein model of Parkinson’s disease Thomas Musacchio, James B. Koprich \u003ci\u003eand\u003c\/i\u003e Chi Wang Ip\u003c\/p\u003e \u003cp\u003e44. Linking the leucine-rich repeat kinase 2 gene, animal models, and Parkinson’s disease Yulan Xiong \u003ci\u003eand\u003c\/i\u003e Jianzhong Yu\u003c\/p\u003e \u003cp\u003e45. Neuroscience of Parkinson’s disease: recommended reading and resources Rajkumar Rajendram, Vinood B. Patel \u003ci\u003eand\u003c\/i\u003e Victor R. Preedy\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Neurosciences [\u003ca title=\"See our other books on Neurosciences\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Neurosciences%20%5BPSAN%5D%22\"\u003ePSAN\u003c\/a\u003e], Physiology [\u003ca title=\"See our other books on Physiology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Physiology%20%5BMFG%5D%22\"\u003eMFG\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Academic Press","offers":[{"title":"Default Title","offer_id":46648717934872,"sku":"9780128159507","price":135.65,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780128159507.jpg?v=1694093538","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/genetics-neurology-behavior-and-diet-in-parkinsons-disease-the-neuroscience-of-parkinson-s-disease-volume-2-hardback-9780128159507","provider":"Freshly Printed Books","version":"1.0","type":"link"}